Educational Qualifications

Ph.D.

Academic Affiliations

• Currently working as assistant professor in Vivekanand Education Society's College of Pharmacy,
• Worked as executive in corporate Quality Assurance department, Micro Labs Ltd, Bangalore

Professional Affiliations

Assistant Professor, Vivekanand Education Society's College of Pharmacy, Mumbai

Teaching

• Pharmaceutics,
• Microbiology,
• Biochemistry,
• Social
• Preventive Pharmacy
  

Research
Area Of Research

• Anti- Cancer,
• Network Pharmacology,
• Molecular Modelling.
  

Publications

1. Development and Validation of Stability-indicating method for the determination of Pregabalin by RP- HPLC. Journal: International Journal of Advance Research, Ideas, and Innovations in Technology. (2018).

2. Targeting small molecules tyrosine kinases by polyphenols: New move towards anti-Tumour drug discovery. Journal: Current drug discovery technologies (2019).

3. Synthesis, biological investigation and docking study of novel chromen derivatives as anticancer agents.Journal: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti- Cancer Agents) (2020).

4. Chemomodulatory effects of Alysicarpus Vaginalis extract via mitochondria-dependent apoptosis and necroptosis in breast cancer. Journal: Nutrition and Cancer (2020).

5. Exploring Molecular network and docking analysis of Osimertinib in cancer Cascade: Need for Drug Repurposing. Journal: Journal of cancer Science and Research (2020).

6. A network pharmacology- based approach to explore potential targets of Caesalpinia Pulcherima: An Update prototype in drug discovery. Journal: Nature: Scientific reports (2020).

7. Development of Novel Anti-Cancer Agent Targeting Angiogenesis in Colorectal Cancer. Journal: Journal of Pharmacy & Bioallied Sciences. (2021).

8. Network Analysis and Molecular Mapping for SARS-CoV-2 to reveal drug targets and Repurposing of clinically developed drugs. Journal: Elsevier: Virology. (2020).

9. Evaluation of In vitro Anticancer, Antimicrobial and Antioxidant activities of new Cu(II) complexes derived from 4(3H)-quinazolinone: Synthesis, crystal structure and molecular docking studies. Journal: Journal of Molecular Structure. (2021).

10. Alysicarpus vaginalis Bio-Actives as ESR Signaling Pathway Inhibitor for Breast Cancer Treatment: A Network Pharmacology Approach. Journal: Nutrition and Cancer. (2021).

11. Design and synthesis of N-4-(substituted benzylidene)-N-2- (4-chloropyrimidin-2-yl)- 6,7- dimethoxyquinazoline-2,4- diamines as Anticancer agents. Journal: Malaysian Journal of Chemistry. (2022).

12. Dual targeting of VEGFR-2 and c-MET kinases via the design and synthesis of substituted benzylidene- 6-(5- chloropyrimidine-2-yl) -9H- purine-2,6- diamine derivatives as angiogenesis inhibitor. Journal: Rasayan journal of chemistry. (2022).

13. Book Chapter: Novel Green and Sustainable materials and their applications. Publisher: Cambridge Scholars. (2024).

Patents

1. Novel 2-styryl-1-methyl-1,4,5,6-tetrahydropyrimidines as fumarate reductase inhibitors. (Indian patent application no.: 202021043067).

2. Novel N-4-(substitutedaryl)-N-2-(4-chloropyrimidin-2-yl)-6,7-dimethoxyquinazoline 2,4diamines as anti-cancer agents. (Indian patent application no.: 202221007599).

Projects

-

Awards and Honors

-